|
2.13 ETIOLOGIE - NDMA
|
|
|
EMA update on metformin diabetes medicines [EMA]
|
|
|
|
|
|
Patients in the EU should continue taking their metformin medicines as normal. The risk from not having adequate diabetes treatment far outweighs possible effects of the low levels of NDMA seen in tests. Healthcare professionals should remind patients of the importance of keeping their diabetes under control.
|
|
|
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
|
5.12.8 IMMUNOTHÉRAPIES - ECONOMIE
|
|
|
|
5.2.6 PHARMA - BIOTECH
|
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
5.7 SABCS
|
|
|
|
5.8.1 ASH - COMMUNIQUÉS
|
|
|
|
5.8.2 ASH - PHARMA
|
|
|
|
5.8.4 ASH - CAR-T
|
|
|
|
|
5.8.5 ASH - MYÉLOME MULTIPLE
|
|
|
|
|
|
|
|
|
5.8.6 ASH - LEUCÉMIES
|
|
|
|
5.8.6.1 ASH - LEUCÉMIES - ACALABRUTINIB
|
|
|
|
|
5.8.6.2 ASH - LEUCÉMIES - IBRUTINIB
|
|
|
|
|
|
5.8.6.3 ASH - LEUCÉMIES - VENETOCLAX
|
|
|
|
|
|
5.8.7 ASH - LYMPHOMES
|
|
|
|
|
|
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
|
|
6.10.1 POLITIQUES (USA)
|
|
|
|
6.11 PATIENTS
|
|
|